Bruce Urdang
About Bruce S. Urdang
Bruce S. Urdang is an independent director of Creative Medical Technology Holdings (CELZ) serving since December 2021. He is an attorney in private practice since 1989 and a long‑tenured professor at Northern Arizona University’s School of Hotel and Restaurant Management since 1989; he holds a J.D. from St. John’s University School of Law and a B.A. in political science from SUNY Oneonta. As of the 2025 proxy, his age is 67 (was 65 in 2024), and he is credited with legal and business expertise supporting board service .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Law Offices of Bruce S. Urdang, J.D. | Attorney (real estate, business transactions, commercial litigation) | 1989–present | Legal and business experience cited as qualifying credentials |
| Northern Arizona University, School of Hotel & Restaurant Management | Professor | 1989–present | Academic experience noted among qualifications |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Northern Arizona University | Professor | 1989–present | Non‑corporate academic appointment |
| Other public company boards | None disclosed | — | CELZ proxy biographies list no other public company directorships for Mr. Urdang |
Board Governance
| Committee | Membership | Chair | Key Responsibilities (summary) |
|---|---|---|---|
| Audit Committee | Member | Susan Snow | Oversees auditor selection, financial reporting, internal controls, risk assessment, related‑party reviews, and pre‑approval of audit/non‑audit services |
| Compensation Committee | Member | Bruce S. Urdang | Oversees executive/director compensation, incentive/equity plans, and administration of equity plans |
| Corporate Governance & Nominating Committee | Member | Susan Snow | Board/committee composition, evaluations, governance guidelines, director nominations |
| Year | Board Meetings Held | Director Attendance Disclosure |
|---|---|---|
| 2021 | 3 | Each director attended ≥75% of Board/committee meetings; Board also acted 13 times by unanimous written consent |
| 2022 | 9 | Each director attended ≥75% of Board/committee meetings |
| 2023 | 5 | Each director attended ≥75% of Board/committee meetings |
| 2024 | 8 | Each director attended ≥75% of Board/committee meetings |
- Independence: CELZ discloses three independent directors under Nasdaq rules; Mr. Urdang is a non‑employee director and serves on fully independent audit/comp/CG&N committees .
- Board leadership: CEO also serves as Chair; no Lead Director; Board asserts structure appropriate for size, with independent directors providing oversight .
Fixed Compensation
| Year | Annual Retainer (Cash/Stock) | Committee Chair Fees | Total Director Compensation | Structure Notes |
|---|---|---|---|---|
| 2022 | $80,000 | $20,000 (Compensation Committee Chair) | $100,000 for Urdang; Option Awards $0 | Non‑employee directors: $80k retainer + $20k per chaired committee; amounts may be paid in combination of cash and stock |
| 2023 | $80,000 | $20,000 (Compensation Committee Chair) | $100,000 for Urdang; Option Awards $0 | Program unchanged; no director options reported |
| 2024 | $80,000 | $20,000 (Compensation Committee Chair) | $100,000 for Urdang; Option Awards $0 | Program unchanged; fees may be in cash and stock |
Performance Compensation
- No performance‑linked components disclosed for non‑employee directors; compensation comprised of retainer and chair fees; Option Awards reported as $0 for 2022–2024 for Mr. Urdang .
- CELZ states director fees “may be paid” in a combination of cash and stock, but no RSU/PSU/option grants are shown for Mr. Urdang in 2022–2024 director compensation tables .
Other Directorships & Interlocks
| Person | Current Public Boards | Committee Roles Elsewhere | Interlocks/Relationships |
|---|---|---|---|
| Bruce S. Urdang | None disclosed in CELZ proxies | None disclosed | No related‑party board interlocks identified in CELZ proxies |
Expertise & Qualifications
- Legal practice in real estate/business transactions and commercial litigation (since 1989); academic experience at NAU (since 1989); J.D. (St. John’s) and B.A. (SUNY Oneonta) .
- Governance skillset: chairs Compensation Committee; serves on Audit and CG&N committees; supports risk oversight and compensation policy governance .
Equity Ownership
| Holder | Shares Beneficially Owned (Q3 2022) | % (Q3 2022) | Shares Beneficially Owned (Q3 2023) | % (Q3 2023) | Shares Beneficially Owned (Q1/Q3 2024) | % (Q1/Q3 2024) | Shares Beneficially Owned (Q3 2025/Oct 2025) | % (Q3/Oct 2025) |
|---|---|---|---|---|---|---|---|---|
| Bruce S. Urdang | -0- | * | -0- | * | -0- (June 2024) ; -0- (Nov 2024) | * | -0- (Oct 2025) ; -0- (Oct 2025) | * |
- “*” denotes less than 1% beneficial ownership per CELZ disclosures .
Governance Assessment
- Alignment risk: Mr. Urdang reported zero beneficial ownership in CELZ across 2022–2025 proxies, signaling limited “skin‑in‑the‑game” despite committee leadership responsibilities .
- Committee effectiveness: As Compensation Committee Chair, Mr. Urdang oversees pay governance; the director pay framework is simple (retainer + chair fee) with no disclosed equity grants to him in 2022–2024, minimizing pay complexity and potential misalignment incentives .
- Attendance/engagement: CELZ reports each director met the ≥75% attendance threshold for Board/committee meetings in 2021–2024, indicating baseline engagement; individual attendance percentages are not disclosed .
- Independence and oversight context: The CEO also serves as Chair and the Board has no Lead Independent Director, putting additional weight on independent committees where Mr. Urdang serves/chairs to provide counterbalance and investor‑confidence‑critical oversight .
RED FLAGS
- Zero CELZ share ownership reported by Mr. Urdang across multiple years (2022–2025), which may undermine ownership alignment perceptions among investors .
- Combined CEO‑Chair and no Lead Independent Director heightens reliance on committee chairs (including Mr. Urdang) for independent oversight .
Related‑party exposure
- CELZ discloses a formal related‑person transactions policy administered by the Audit Committee (independent membership includes Mr. Urdang); no specific related‑party transactions tied to Mr. Urdang are disclosed in the proxies reviewed .